First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator [0.03%]
一种新型除颤补丁式穿戴心脏复律除颤器的人体安全与有效性研究
Milan Chovanec,Jan Petrů,Pavel Hála et al.
Milan Chovanec et al.
Aims: Wearable cardioverter-defibrillators (WCDs) are indicated in patients at risk of sudden cardiac arrest who are not immediate candidates for implantable defibrillator therapy. Limitations of existing WCDs include poo...
First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator [0.03%]
一种新型除颤贴的人体安全和有效性研究——与可穿戴式心脏复律除颤器的对照研究
Milan Chovanec,Jan Petrů,Pavel Hála et al.
Milan Chovanec et al.
Aims: Wearable cardioverter-defibrillators (WCDs) are indicated in patients at risk of sudden cardiac arrest who are not immediate candidates for implantable defibrillator therapy. Limitations of existing WCDs include poo...
Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study) [0.03%]
脉冲场消融与高功率短时程射频消融进行肺静脉隔离治疗阵发性房颤的疗效、安全性及长期随访（PRIORI研究）
Nico Reinsch,Anna Füting,Stefan Hartl et al.
Nico Reinsch et al.
Aims: Pulsed field ablation (PFA) is a novel, non-thermal, cardiac tissue-selective ablation modality. To date, radiofrequency (RF)-guided high-power short-duration (HPSD) ablation represents the gold standard besides cry...
Response to the letter by Blank et al. regarding the article: 'LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial' [0.03%]
致Blank等人的信：关于“用于老年阵发性房颤患者的直线加速器立体定向心律失常放射消融（STAR）：一项前瞻性Ⅱ期临床试验”的回复
Antonio Di Monaco,Alba Fiorentino,Massimo Grimaldi
Antonio Di Monaco
Evaluation of tricuspid valve regurgitation following transvenous rotational mechanical lead extraction [0.03%]
经静脉旋转机械式电极导线拔除后三尖瓣反流的评价
Federico Migliore,Raimondo Pittorru,Manuel De Lazzari et al.
Federico Migliore et al.
Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience [0.03%]
局灶性场导航消融治疗室性心律失常的有效性和安全性：来自两家中心的经验
Petr Peichl,Alan Bulava,Dan Wichterle et al.
Petr Peichl et al.
Aims: A pulsed electric field (PF) energy source is a novel potential option for catheter ablation of ventricular arrhythmias (VAs) as it can create deeper lesions, particularly in scarred tissue. However, very limited da...
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021 [0.03%]
1990至2021年全球心房颤动/心房扑动负担及归因危险因素分布
Siyuan Cheng,JinZheng He,Yuchen Han et al.
Siyuan Cheng et al.
Background: To devise effective preventive measures, a profound understanding of the evolving patterns and trends in atrial fibrillation (AF) and atrial flutter (AFL) burdens is pivotal. Our study was designed to quantify...
A large footprint focal catheter toggling between pulsed field and radiofrequency energy: first clinical experience for ventricular tachycardia ablation [0.03%]
一种大型焦斑导管在脉冲电场和射频能量之间切换治疗室性心动过速的首次临床经验
Luigi Pannone,Ioannis Doundoulakis,María Cespón-Fernández et al.
Luigi Pannone et al.
Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation [0.03%]
心力衰竭合并房颤患者的右室起搏升级至双室起搏的益处分析
Béla Merkely,Robert Hatala,Eperke Merkel et al.
Béla Merkely et al.
Aims: Recommendations on cardiac resynchronization therapy (CRT) in patients with atrial fibrillation or flutter (AF) are based on less robust evidence than those in sinus rhythm (SR). We aimed to assess the efficacy of C...
Randomized Controlled Trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2024 Jul 2;26(7):euae179. DOI:10.1093/europace/euae179 2024